AGP Executive Report
Last update: 8 hours agoHealthcare & Pharma Dealmaking: Alfasigma has agreed to acquire Nordic Group (Nordic Pharma) to expand its rheumatology and specialty care footprint across Europe, plus Canada and Japan, adding about 265 employees and bringing Nordic’s rheumatoid arthritis and women’s health, critical care, and ophthalmology products into its portfolio. Infectious Disease & Innovation: SNIPR reported a peer-reviewed expanded access case in Clinical Infectious Diseases describing SNIPR001 (engineered CRISPR-enhanced medicine) used in a kidney transplant patient with rare multidrug-resistant E. coli malakoplakia, with abdominal lesion regression and no phage-related adverse events noted. Public Health & Climate Stress: Italy’s extreme heat continues to drive major health alerts and strain daily life, with reports of cities on red alert and power-saving measures as Europe braces for further heatwaves. Health Policy & Access: A new report highlights how more Italians are booking private healthcare outside office hours, pointing to growing pressure on availability and scheduling in the public system. Wellness & Lifestyle: Ferragosto (Aug. 15) is expected to shut down many services, including doctors’ offices and most shops, which can affect routine care and medication access.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![[Latest] Global Virtual Clinical Trials Market Size/Share Worth USD 15.8 Billion by 2034 at a 5.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)](https://ml.globenewswire.com/Resource/Download/b0be38a8-093a-4d2c-9f28-3d6cf9e92e17/adobe-express-file.jpg)
